Welcome to our dedicated page for Mirion Technologies SEC filings (Ticker: MIR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Mirion Technologies, Inc. filings document operating results, executive compensation, proxy matters and financing arrangements for a radiation detection, measurement, analysis and monitoring company serving nuclear, medical, defense and research markets. Form 8-K reports furnish financial-results releases, guidance updates, material definitive agreements, credit-agreement refinancing activity and other material events.
Proxy filings disclose governance and compensation subjects, including equity-award tables, pay-versus-performance information and a performance-vesting stock option award for the company's chief executive officer. The filing record also covers debt terms at operating subsidiaries and material-event disclosures tied to changes in the company's nuclear technology portfolio.
Mirion Technologies reported Q2 2026 revenue of $266.8 million, up from $222.9 million a year earlier, driven by higher product and service sales. Gross profit rose to $133.1 million, with income from operations increasing to $17.9 million from $9.9 million.
Net income attributable to Mirion was $7.7 million for the quarter (diluted EPS $0.03), compared with $8.3 million (EPS $0.03) in Q2 2025. For the first half, revenue was $524.4 million and net income attributable was $4.3 million, lower than $8.6 million a year earlier, partly reflecting higher amortization and foreign currency losses.
As of June 30, 2026, Mirion held $418.7 million in cash and cash equivalents and generated $77.4 million of operating cash flow in the first half. Total debt under its credit facility was $451.6 million, with additional $775.0 million of convertible senior notes outstanding. Remaining performance obligations totaled $1,138.6 million, with a significant portion expected to convert to revenue by 2029.
Mirion Technologies reported second quarter 2026 revenue of $266.8 million, up 19.7% from $222.9 million a year earlier, driven by growth in both product and service revenues. GAAP net income was $8.1 million versus $8.5 million, and GAAP net earnings per share were $0.03 compared with $0.04. Adjusted EBITDA increased 27.5% to $65.3 million, yielding a 24.5% adjusted EBITDA margin.
Orders excluding the Paragon and Certrec acquisitions were $229 million, up 10% from $208 million; including these acquisitions, orders were $291 million, a 40% increase. Net cash provided by operating activities for the first half of 2026 was $77.4 million, and cash and cash equivalents were $418.7 million as of June 30, 2026. The company reaffirmed full-year 2026 guidance, including total revenue growth of approximately 22.0%–24.0%, organic revenue growth of 5.0%–7.0%, adjusted EBITDA of $285 million–$300 million with a 25.0%–26.0% margin, adjusted free cash flow of $155 million–$175 million, and adjusted EPS of $0.48–$0.55 per share.
Mirion Technologies, Inc. disclosed a new expatriation arrangement for Loïc Eloy, its President, Nuclear & Safety Group and a named executive officer. He is being seconded from France to the United States and will continue reporting to CEO Thomas D. Logan.
During this U.S. assignment, Mr. Eloy will receive an annual base salary of USD 415,000 and remain eligible for the company’s annual executive bonus program, with a target bonus equal to 50% of his base salary. Mirion will also provide customary expatriation benefits such as housing, relocation, education, travel, tax, and social protection support.
The assignment is expected to start after required work authorization is obtained and will initially run for 12 months, with the possibility of extension by mutual written agreement for up to 36 months in total. The detailed terms are set out in a letter agreement and secondment addendum filed as exhibits.
Kingsley Lawrence D reported acquisition or exercise transactions in this Form 4 filing.
Mirion Technologies director Lawrence D. Kingsley reported a stock grant of 1,095 shares of Class A Common Stock, valued at $17.46 per share. The shares were issued as his quarterly director retainer, which he elected to receive in vested stock instead of cash. Following this grant, he directly holds 72,525 shares. He also reports indirect holdings of 3,191,075 shares through the Lawrence D. Kingsley Revocable Trust and 159,000 shares each through the Lawrence D. Kingsley 2026 GRAT I and 2026 GRAT II.
Kingsley Lawrence D reported acquisition or exercise transactions in this Form 4 filing.
Mirion Technologies director Lawrence D. Kingsley received a stock-based compensation grant. He was awarded 7,383 shares of Class A Common Stock as a restricted stock unit grant at a stated price of $0.00 per share, increasing his direct holdings to 71,430 shares. The units vest on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, subject to his continued Board service.
Bockhorst Kenneth reported acquisition or exercise transactions in this Form 4 filing.
Mirion Technologies director Kenneth Bockhorst received an equity award in the form of restricted stock units. On the reported date, he was granted 7,383 shares of Class A common stock as a stock award at no cash cost, increasing his direct holdings to 77,258 shares.
The footnote explains these restricted stock units vest on the earlier of the first anniversary of the grant date or the company’s next annual stockholder meeting, if he continues serving as a non-employee director through that date. This reflects routine board compensation rather than an open-market purchase.
CASCELLA ROBERT reported acquisition or exercise transactions in this Form 4 filing.
Mirion Technologies director Robert Cascella received an equity award in the form of restricted stock units. The grant covers 7,383 shares of Class A Common Stock at no cash cost, increasing his direct holdings to 60,801 shares after the transaction.
The restricted stock units will vest on the earlier of the first anniversary of the grant date or the date of the next annual stockholder meeting, as long as Cascella continues to serve as a non-employee director on the Board through that vesting date. This is a routine, compensation-related equity grant rather than an open-market share purchase.
Mirion Technologies director Steven W. Etzel reported an equity grant of 7,383 shares of Class A Common Stock in the form of restricted stock units. The award carries no cash exercise price.
These restricted stock units vest on the earlier of the first anniversary of the grant date or the date of the next annual stockholder meeting, conditioned on his continued service as a non-employee director. After this grant, Etzel directly holds 87,448 shares of Mirion Class A Common Stock, so the award modestly increases his existing ownership stake.
KUO JOHN W reported acquisition or exercise transactions in this Form 4 filing.
Mirion Technologies director John W. Kuo received an equity award of 7,383 shares of Class A common stock in the form of restricted stock units. These units vest on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, as long as he continues serving on the board. After this grant, he directly holds 80,119 shares. This is a routine, compensation-related award rather than an open-market purchase.
Markopoulos Jody reported acquisition or exercise transactions in this Form 4 filing.
Mirion Technologies director Jody Markopoulos received an equity award of 7,383 restricted stock units tied to the company’s Class A Common Stock. These units will vest on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, as long as she continues serving on the Board through that date.
After this grant, Markopoulos directly holds 81,509 shares, reflecting routine, compensation-related stock awards rather than an open-market purchase.